How can an applicant show that a biological material is known and readily available?
An applicant can demonstrate that a biological material is known and readily available through various means. According to MPEP 2404.01, some factors that may serve as evidence include: Commercial availability References to the biological material in printed publications Declarations of accessibility by those working in the field Evidence of predictable isolation techniques An existing deposit…
Read MoreWhat risks does an applicant take when relying on evidence of accessibility other than a deposit?
When an applicant relies on evidence of accessibility other than a deposit to show that a biological material is known and readily available, they take on certain risks. According to MPEP 2404.01: “Those applicants that rely on evidence of accessibility other than a deposit take the risk that the patent may no longer be enforceable…
Read MoreWhat does “known and readily available” mean in the context of biological materials for patent applications?
“Known and readily available” refers to the level of public accessibility to a necessary component of an invention disclosure that is consistent with the ability to make and use the invention. According to MPEP 2404.01: “To avoid the need for a deposit on this basis, the biological material must be both known and readily available…
Read MoreHow long must a biological material deposit be maintained for patent purposes?
The duration of a biological material deposit for patent purposes is specified in the USPTO regulations. According to MPEP 2404.01, which references 37 CFR 1.806: “The term of deposit is “at least thirty (30) years and at least five (5) years after the most recent request” for a sample; the agreement sufficiently ensures that the…
Read MoreHow does commercial availability affect the determination of whether a biological material is known and readily available?
Commercial availability can be a factor in determining whether a biological material is known and readily available, but it’s not always sufficient on its own. According to MPEP 2404.01: “The Office will accept commercial availability as evidence that a biological material is known and readily available only when the evidence is clear and convincing that…
Read MoreWhat is the significance of a Budapest Treaty deposit for biological materials in patent applications?
A Budapest Treaty deposit can be significant for biological materials in patent applications, but it doesn’t automatically ensure that the material is considered known and readily available. According to MPEP 2404.01: “Even a deposit made under the Budapest Treaty and referenced in a United States or foreign patent document would not necessarily meet the test…
Read More